Trials / Sponsors / Nathan Denlinger
Nathan Denlinger
Academic / Other · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma B-Cell Non-Hodgkin Lymphoma-Recurrent, Diffuse Large B-Cell Lymphoma-Recurrent, Follicular Lymphoma-Recurrent | Phase 1 | 2024-01-29 |